Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4649786016 | Viloxazine hydrochloride (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 4649787013 | Viloxazine hydrochloride | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Viloxazine hydrochloride | Is a | Substance with ether structure | true | Inferred relationship | Existential restriction modifier | ||
| Viloxazine hydrochloride | Is a | Antidepressant | true | Inferred relationship | Existential restriction modifier | ||
| Viloxazine hydrochloride | Is modification of | Viloxazine | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely viloxazine (as viloxazine hydrochloride) 100 milligram/1 each prolonged-release oral capsule (clinical drug) | Has precise active ingredient | True | Viloxazine hydrochloride | Inferred relationship | Existential restriction modifier | 1 |
| Product containing precisely viloxazine (as viloxazine hydrochloride) 150 milligram/1 each prolonged-release oral capsule (clinical drug) | Has precise active ingredient | True | Viloxazine hydrochloride | Inferred relationship | Existential restriction modifier | 1 |
| Product containing precisely viloxazine (as viloxazine hydrochloride) 200 milligram/1 each prolonged-release oral capsule (clinical drug) | Has precise active ingredient | True | Viloxazine hydrochloride | Inferred relationship | Existential restriction modifier | 1 |
This concept is not in any reference sets
FHIR